Form 4 for DNA Ginkgo Bioworks Holdings, Inc.
Accepted 2022-12-21 00:00:00 ET · period of report 2022-12-19 · accession 0001127602-22-028090 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-12-21 | 2022-12-19+ | DNA | Kelly Jason R | See remarks, Dir | S - Sale | $1.66 | -615.2K | 18.39M | -3% | -$1.02M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-12-19 | S | D | 206,449 | $1.67 | 18,802,367 | D | — | — | |
| 2 | Common | Class A Common Stock | 2022-12-20 | S | D | 408,767 | $1.66 | 18,393,600 | D | — | — |